Südafrika startet historischen ersten HIV-Impfstoffversuch am Menschen

> South Africa has taken a major step forward in the fight against HIV, as Africa moves closer to a potential vaccine.
>
> The first-in-human clinical trial of a new HIV vaccine has officially launched in Cape Town, marking a historic milestone for the continent.
>
> South Africa has an estimated 8 million people living with HIV, making it the country with the largest epidemic.
>
> The study was launched at the [Desmond Tutu HIV Foundation](https://en.wikipedia.org/wiki/Desmond_Tutu_HIV_Foundation) at Groote Schuur Hospital.
>
> The groundbreaking HIV trial has already enrolled its first group of 20 HIV-negative volunteers who will help scientists assess the safety and immune response of the vaccine.
>
> Leading health researcher at Wits University, Professor [Glenda Gray](https://en.wikipedia.org/wiki/Glenda_Gray), said this early phase of the study was a critical step in the long and complex journey toward an effective HIV vaccine.
>
> Gray said: “What we are trying to attain is called a functional cure so that the interventions we give keeps the virus at bay so you don’t have to be on treatment”.
>
> This breakthrough trial places Africa at the forefront of global HIV vaccine research.
>
> In 2023, approximately 25.6 million people were living with HIV in sub-Saharan Africa.
>
> If it is successful, the study could bring renewed hope to millions across Africa and the world.